Phospho-TAK1 (Ser192) Rabbit Polyclonal Antibody (Cy5)
Phospho-TAK1 (Ser192) Rabbit Polyclonal Antibody (Cy5) is a Cy5 conjugated antibody targeting MAP3K7. This antibody is suitable for ICC, IF. It exhibits reactivity with Human samples.
Product Specifications
Product Name Alternative
MAP3K7 (phospho S192) ; TAK1 (phospho Ser192) ; MAP3K7; Mitogen-activated protein kinase kinase kinase 7; Transforming growth factor-beta-activated kinase 1; TGF-beta-activated kinase 1; MAP3K 7; MAPKKK7; Mitogen activated protein kinase kinase kinase 7; TAK1; TGF beta activated kinase 1; TGF1a; Transforming growth factor beta activated kinase 1; M3K7_HUMAN; Map3k7; MEKK7; TGF-beta-activated kinase 1; TGF1a; Transforming growth factor-beta-activated kinase 1.
Reactivity
Human
Immunogen
KLH conjugated Synthesised phosphopeptide derived from human TAK1 around the phosphorylation site of Ser192 KG (p-S) AA
Target
MAP3K7
Clonality
Polyclonal
Conjugation
Cy5
Field of Research
Signal Transduction
Purification
Affinity purified by Protein A
Concentration
1mg/ml
Dilution
IF=1:100-500, ICC/IF=1:100-500
Storage Conditions
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Notes
For research use only.
Prediction Reactivity
Bovine, Equine, Gallus, Mouse, Porcine, Rabbit, Rat
Tested Applications
ICC, IF
Host or Source
Rabbit
Preservative
0.01M TBS (pH7.4) with 1% rAlbumin, 0.02% Proclin300 and 50% Glycerol.
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-B621215-250MG 250 mg
Boc-(S)-3-Amino-4-(2,4,5-trifluorophenyl)butyric Acid
Sign In for Pricing
View Details 
ARP46381_P050-FITC 100 µL
IL1RL2 Antibody - N-terminal region : FITC (ARP46381_P050-FITC)
Sign In for Pricing
View Details ARP64263_P050 100 µL
Sostdc1 Antibody - C-terminal region (ARP64263_P050)
Sign In for Pricing
View Details VAng-Wyb2716-200gEcoli 200 µg (E. coli)
Recombinant Neisseria Gonorrhoeae obg Protein (aa 1-384) (strain ATCC 700825 / FA 1090)
Sign In for Pricing
View Details 